CSIMarket
 


Targacept Inc  (TRGT)
Other Ticker:  
 

Targacept Inc's Quick Ratio

TRGT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




TRGT Quick Ratio (Jun 30 2015)
II. Quarter
(Mar 31 2015)
I. Quarter
(Dec 31 2014)
IV. Quarter
(Sep 30 2014)
III. Quarter
(Jun 30 2014)
II. Quarter
Y / Y Current Liabilities Change -78.08 % -60.44 % -73.46 % -69.8 % -12.89 %
Y / Y Cash & cash equivalent Change 2.11 % 7.73 % 16.31 % 1.2 % -2.48 %
Quick Ratio MRQ 60.73 26.84 36.85 30.48 13.03
Overall Ranking # # # # #
Seq. Current Liabilities Change -57.9 % 33.94 % -9.28 % -57.16 % -24 %
Seq. Cash & cash equivalent Change -4.76 % -2.45 % 9.67 % 0.21 % 0.48 %



Quick Ratio second quarter 2015 Comment
Current Liabilities decreased faster than Targacept Inc's Cash & cash equivalent, this led to improvement in Targacept Inc's Quick Ratio to 60.73, Quick Ratio remained below Targacept Inc average.

Within Biotechnology & Pharmaceuticals industry 2 other companies have achieved higher Quick Ratio than Targacept Inc in second quarter 2015. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are TRGT Segments?
See Quick Ratio TRGT on the trailing twelve month basis
Quick Ratio second quarter 2015 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 3
Healthcare Sector # 6
Overall Market # 59


Quick Ratio Statistics
High Average Low
60.73 19.82 8.41
(Jun 30 2015)   (Dec 31 2013)




Financial Statements
Targacept Inc's Current Liabilities $ 2 Millions Visit TRGT's Balance sheet
Targacept Inc's Cash & cash equivalent $ 100 Millions Visit TRGT's Balance sheet
Source of TRGT's Sales Visit TRGT's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2015, within Biotechnology & Pharmaceuticals Industry Quick RatioJun 30 2015 MRQ Cash & cash equivalentJun 30 2015 MRQ Current Liabilities
Salarius Pharmaceuticals inc   119.88 $ 106.012  Millions$ 0.884  Millions
Alder Biopharmaceuticals Inc  63.81 $ 428.413  Millions$ 6.714  Millions
Targacept Inc  60.73 $ 99.774  Millions$ 1.643  Millions
Iovance Biotherapeutics inc   60.20 $ 112.336  Millions$ 1.866  Millions
Cadus Corp  59.56 $ 10.579  Millions$ 0.178  Millions
Optec International, Inc.  52.81 $ 0.033  Millions$ 0.001  Millions
Cidara Therapeutics Inc   39.86 $ 122.301  Millions$ 3.068  Millions
Adverum Biotechnologies Inc   35.56 $ 279.640  Millions$ 7.864  Millions
Genocea Biosciences Inc   33.81 $ 74.595  Millions$ 2.206  Millions
Bluebird Bio Inc   28.91 $ 810.507  Millions$ 28.033  Millions
Protara Therapeutics Inc   27.03 $ 74.736  Millions$ 2.765  Millions
Nutrastar International Inc.  26.89 $ 137.731  Millions$ 5.122  Millions
Neurocrine Biosciences Inc   21.92 $ 384.720  Millions$ 17.553  Millions
Atara Biotherapeutics Inc   21.70 $ 155.031  Millions$ 7.144  Millions
Kite Pharma, Inc.  20.20 $ 392.888  Millions$ 19.450  Millions
Immunitybio Inc   19.94 $ 120.437  Millions$ 6.039  Millions
Pulmatrix Inc   19.22 $ 25.507  Millions$ 1.327  Millions
Spark Therapeutics Inc   16.65 $ 223.047  Millions$ 13.394  Millions
Organovo Holdings Inc   16.46 $ 86.000  Millions$ 5.225  Millions
Lixte Biotechnology Holdings Inc   16.02 $ 1.251  Millions$ 0.078  Millions
La Jolla Pharmaceutical Company  14.20 $ 36.045  Millions$ 2.538  Millions
Applied Genetic Technologies Corp  13.28 $ 61.641  Millions$ 4.642  Millions
Receptos, Inc.  13.16 $ 579.118  Millions$ 43.994  Millions
Foamix Pharmaceuticals Ltd   12.83 $ 56.364  Millions$ 4.392  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

KOSS's Profile

Stock Price

KOSS's Financials

Business Description

Fundamentals

Charts & Quotes

KOSS's News

Suppliers

KOSS's Competitors

Customers & Markets

Economic Indicators

KOSS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071